← Eichor
Study identifier: NCT07039136 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Virtual Reality Mirrors Therapy Usability

Condition: Healthy · Stroke  ·  Sponsor: Abant Izzet Baysal University

PhaseNA
Planned participants172
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

Mirror therapy has been shown to support motor recovery by stimulating neural mechanisms through visual feedback. Recent technological advancements, particularly in virtual reality (VR), have enabled the development of more immersive and interactive rehabilitation tools. This study focuses on evaluating the usability of a novel, Leap Motion-based Virtual Reality Mirror Therapy (VRMT) system designed to enhance upper limb rehabilitation in stroke patients by combining traditional mirror therapy principles with engaging, gamified digital environments.

This description comes directly from the study's public registry record.

Talk to the study team

Ömer Pala, PhD  ·  +90 532 797 57 16  ·  omerosman.pala@ibu.edu.tr

ramazan kurul, PhD  ·  +905436414731  ·  ramazankurul@ibu.edu.tr

Always discuss trial participation with your own doctor first.

Locations (2)

Faculty of Health Sciences Bolu Abant Izzet Baysal UniversityBolu, Merkez, Turkey (Türkiye)Recruiting
Bolu Abant Izzet Baysal University Department of Physiotherapy and RehabilitationBolu, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07039136